Long-Term Outcomes in Coronary Artery Bypass Graft Patients Using Internal Thoracic Artery with Ipsilateral

Yung-Szu Wu1, Shih-Rong Hsieh1,2, Hao-Ji Wei1,2

  • 1Department of Cardiovascular Surgery, Cardiovascular Center, Taichung Veterans General Hospital, Taichung.

Insights

Coronary artery bypass grafting (CABG) using internal thoracic artery (ITA) grafts in hemodialysis patients with arteriovenous vascular access shows improved outcomes. ITA CABG is associated with a lower risk of death compared to non-ITA CABG.

Area of Science:

  • Cardiovascular Surgery
  • Nephrology
  • Vascular Access

Background:

  • Evaluating long-term outcomes of coronary artery bypass grafting (CABG) in hemodialysis (HD) patients with arteriovenous (AV) fistulae or grafts.
  • Assessing the impact of internal thoracic artery (ITA) graft use on mortality in this specific patient population.

Purpose of the Study:

  • To compare the long-term results of CABG using ITA grafts in HD patients with ipsilateral or contralateral AV vascular access (AVVA).
  • To determine if ITA graft use in CABG impacts survival rates in end-stage renal disease (ESRD) patients with AVVA.

Main Methods:

  • A cohort of 76 ESRD patients undergoing CABG with AVVA between March 2007 and May 2017 were analyzed.
  • Patients were divided into three groups: ITA graft ipsilateral to AVVA (Group A), contralateral ITA graft (Group B), and no ITA graft (Group C).
  • The primary endpoint was all-cause mortality, with an average follow-up of 34.4 months.

Main Results:

  • All-cause mortality was 26.09% in Group A, 36.36% in Group B, and 58.62% in Group C (p=0.04).
  • No significant difference in death rate was observed between ipsilateral and contralateral ITA graft groups.
  • Patients receiving ITA CABG demonstrated a significantly lower risk of death (HR 0.41, p=0.015) compared to those without ITA grafts.

Conclusions:

  • Ipsilateral ITA graft use in CABG for HD patients with AVVA does not increase mortality risk compared to contralateral use.
  • The utilization of ITA grafts in CABG is associated with improved long-term outcomes in hemodialysis patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
909
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
387
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
220
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
340
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
601
Arteries and Arterioles01:16

Arteries and Arterioles

Arteries, the vasculature responsible for transporting blood from the heart, possess robust walls capable of enduring the elevated pressures exerted by the heartbeat. Arteries near the heart are especially thick-walled and enriched with elastic fibers across their three tunics, classifying them as elastic or conducting arteries. These arteries, usually with a diameter exceeding 10 mm, are characterized by their ability to dilate in response to the blood pumped from the heart's ventricles...
6.3K